[ad_1]
"HIV needs to recognize its responsibility as today's producer of pediatric versions of the new gold standard for HIV and children," said Jessica Burry, HIV pharmacist at MSF's Access Campaign. "A full year after ViiV first made available for adults, what we're seeing is the corporation hiding behind bureaucratic excuses for what they're doing. Their apologies are not valid. "
Pricing of the paediatric formulations is also much more relevant to the adult formulations. ViiV sells the adult 50mg dose for approximately US $ 223 per person per year, while for the 25mg and 10mg pediatric formulations, ViiV charges US $ 214 and US $ 115, respectively . If a child needs a dose of 35mg, ViiV would charge US $ 329 per year, over US $ 100 more than than adults pay – and this does not include the two other drugs. Furthermore, triple-drug badtail containing dolutegravir are available for US $ 75 per person per year. Yet another example of how children with HIV is consistently left behind
Source link
